Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has demonstrated an improvement in its financial outlook, as evidenced by the increase in normalized funds from operations (NFFO) estimates for 2025, now projected at $4.80 per share, aligning with management's guidance expectations. Additionally, the company has raised its FFO estimate for 2026 to $5.03 per share, slightly surpassing the consensus forecast of $5.00 per share. These upward revisions reflect a positive trend in the company’s performance and reinforce confidence in its revenue-generating capabilities across its Real Estate Investments and Senior Housing Operating Portfolio segments.

Bears say

National Health Investors Inc. faces a negative outlook primarily due to anticipated lower earnings growth over the next few years, driven by challenges associated with operator transitions and issues. The company's performance may be adversely impacted if the rent reset for its NHC portfolio falls short of investor expectations, coupled with potential weaknesses in deferred rent collections. Additionally, the risk of operational difficulties from one or more operators, possibly exacerbated by future health crises, poses further threats to the REIT's financial stability.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.